Hantz Financial Services, Inc. Infinity Pharmaceuticals, Inc. Transaction History
Hantz Financial Services, Inc.
- $5.69 Billion
- Q1 2025
A detailed history of Hantz Financial Services, Inc. transactions in Infinity Pharmaceuticals, Inc. stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 500 shares of INFI stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500Holding current value
$0% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding INFI
# of Institutions
3Shares Held
1.26MCall Options Held
0Put Options Held
0About INFINITY PHARMACEUTICALS, INC.
- Ticker INFI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 89,277,904
- Description
- Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...